Additional 1.1-mm cryobiopsy trial guided by rapid on-site cytologic evaluation of touch imprint cytology result of small forceps biopsy in peripheral pulmonary lesions: a prospective single-center study
The selective addition of a 1.1-mm CB based on ROSE-TIC results of FB is a safe, feasible, and effective strategy for improving the specific diagnostic yield. This approach may be particularly beneficial for small PPLs of ≤20 mm.
Authors
- Tomoyoshi Inoue
- Keisuke Shiraha (ORCID: https://orcid.org/0009-0005-2383-9532)
- Miho Fujiwara (ORCID: https://orcid.org/0009-0009-3790-4373)
- Yuki Takigawa (ORCID: https://orcid.org/0000-0003-0613-0423)
- Mayu Goda
- Shoichiro Matsumoto
- Keiichi Fujiwara (ORCID: https://orcid.org/0000-0001-8396-4531)
- Kenichiro Kudo
- Jun Nishimura (ORCID: https://orcid.org/0000-0002-2526-0242)
- Hiromi Watanabe (ORCID: https://orcid.org/0000-0002-4094-9080)
- Takuo Shibayama
- Takeru Ichikawa
- Suzuka Matsuoka (ORCID: https://orcid.org/0000-0003-0492-4019)
- Akiko Sato
- Yoko Shinno
- Ken Sato
- Tetsuya Isoda
Institutions
- Okayama Medical Center (JP)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/tlcr-2025-797
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00